Latest Strategic Outlook News

Brightstar Resources has reported promising high-grade drilling results at its Second Fortune and Fish gold mines, indicating potential extensions to mine life and new ore sources for its planned Laverton mill.

Verity Resources has identified a compelling new gold target at its Monument Gold Project in Western Australia through a recent geophysical survey, with drilling set to commence imminently.

Tambourah Metals has identified a significant gold anomaly at its Beatty Park South project through ultrafine soil sampling, prompting plans for follow-up RC drilling to test high-grade mineralisation.

Core Lithium has unveiled an updated mine plan for its Grants deposit at the Finniss Lithium Project, increasing the Ore Reserve by 33% and cutting pre-production capital costs by up to $45 million.

Count Limited reported robust FY2025 financial results marked by significant revenue and profit growth, underpinned by strategic acquisitions and organic expansion. The positive momentum continues into FY2026 Q1 with further gains and a solid M&A pipeline.

Count Limited reports robust FY25 financial results driven by successful acquisitions and organic growth, with promising momentum continuing into FY26. The company’s integrated accounting and wealth services model positions it well amid demographic and market trends.

Alliance Nickel’s binding offtake agreement with Stellantis is terminated due to missed milestones amid tough nickel market conditions, yet renegotiation talks signal ongoing partnership potential.

Metal Bank Limited has successfully closed a $2.42 million entitlement offer, bolstering its capacity to advance gold projects in Western Australia and critical minerals exploration in Queensland.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.

Macquarie Group Limited reported a 3% increase in profit for the half year ended 30 September 2025, driven by strong performances in asset management and capital advisory, while declaring a 35% franked interim dividend of $2.80 per share.

Group 6 Metals has materially improved its debt position by converting warrants under its April 2025 recapitalisation plan, signaling renewed shareholder confidence and operational momentum.

Neuren Pharmaceuticals reported a milestone quarter with DAYBUE net sales reaching US$101.1 million, driving a 24% jump in royalty income. The expanding patient base and community physician uptake signal strong growth ahead.